Autism epidemiology and demographics

Jump to navigation Jump to search

Autism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autism epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autism epidemiology and demographics

CDC on Autism epidemiology and demographics

Autism epidemiology and demographics in the news

Blogs on Autism epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Autism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Most recent reviews estimate a prevalence of 100- 200 cases per 100,000 people for autism, and about 600 per 100,000 for ASD, with ASD averaging a 4.3:1 male-to-female ratio. The number of people known to have autism has increased dramatically since the 1980s, at least partly due to changes in diagnostic practice; the question of whether actual prevalence has increased is unresolved.

Epidemiology and Demographics

Incidence

  • According to National Survey of Children’s Health, by the Autism and Developmental Disabilities Monitoring (ADDM) network, the estimated annual incidence of ASD world wide is 1 child in every 110 children.[1] 
  • The estimated annual incidence of autism in the United states of America is similar to the world estimate, that 1 in 91 children aged 3 to 17 years. 
  • These numbers are similar to regional data
    • In Massachusetts, the incidence of ASD in 2005 was 1 per 108 in children less than 3 years of age.

Prevalence

  • The estimated annual prevalence of is 100– 200 per 100,000 for autism and close to 600 per 100,000 for ASD.[2][3]
  • PDD-NOS is the vast majority of ASD, Asperger's is about 30 per 100,000 and the remaining ASD forms are much rarer.[4]
Reports of autism cases grew dramatically in the U.S. in 1996–2005. It is unknown how much, if any, growth came from changes in autism's prevalence.

Demographics

Gender

  • Males are more commonly affected by ASD than females.[5]
  • The male to female ratio is approximately 4.3 to 1.
  • The ASD sex ratio is greatly modified by cognitive impairment, it may be close to 2:1 with mental retardation and more than 5.5:1 for HFA.

Developed Countries

Australia

  • The national estimates for the prevalence of ASD in Australia ranged from 121 to 357 per 100,000 for children aged 6–12 years.[6]

Denmark

  • The annual estimate of ASD in Denamark is estimated to be 137 per 100,000.[7]
  • A 2003 study reported that the cumulative incidence of autism in Denmark began a steep increase starting around 1990, and continued to grow until 2000, despite the withdrawal of thiomersal- containing vaccines in 1992.
    • For example, for children aged 2–4 years, the cumulative incidence was about 5 new cases per 100,000 children in 1990 and about 45 new cases per 100,000 children in 2000.

United Kingdom

  • The incidence and changes in incidence with time are unclear in the UK.[8]
  • The reported autism incidence in the UK rose starting before the first introduction of the MMR vaccine in 1989.[9]
  • The estimated annual incidence of ASD is 2.98 per 10,000 person.[10]

References

  1. Baird G, Simonoff E, Pickles A; et al. (2006). "Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)". Lancet. 368 (9531): 210–5. doi:10.1016/S0140-6736(06)69041-7. PMID 16844490.
  2. Newschaffer CJ, Croen LA, Daniels J; et al. (2007). "The epidemiology of autism spectrum disorders". Annu Rev Public Health. 28: 235–58. doi:10.1146/annurev.publhealth.28.021406.144007. PMID 17367287.
  3. Caronna EB, Milunsky JM, Tager-Flusberg H (2008). "Autism spectrum disorders: clinical and research frontiers". Arch Dis Child. 93 (6): 518–23. doi:10.1136/adc.2006.115337. PMID 18305076.
  4. Fombonne E (2005). "Epidemiology of autistic disorder and other pervasive developmental disorders". J Clin Psychiatry. 66 (Suppl 10): 3–8. PMID 16401144.
  5. Newschaffer CJ, Croen LA, Daniels J; et al. (2007). "The epidemiology of autism spectrum disorders". Annu Rev Public Health. 28: 235–58. doi:10.1146/annurev.publhealth.28.021406.144007. PMID 17367287.
  6. Williams K, Macdermott S, Ridley G, Glasson EJ, Wray JA (2008). "The prevalence of autism in Australia. Can it be established from existing data?". J Paediatr Child Health. doi:10.1111/j.1440-1754.2008.01331.x. PMID 18564076.
  7. Madsen KM, Lauritsen MB, Pedersen CB; et al. (2003). "Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data". Pediatrics. 112 (3): 604–6. doi:10.1542/peds.112.3.604. PMID 12949291.
  8. "Incidence of autism". National Autistic Society. 2004. Retrieved 2007-12-10.
  9. Kaye JA, del Mar Melero-Montes M, Jick H (2001). "Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis". BMJ. 322 (7284): 460–3. doi:10.1136/bmj.322.7284.460. PMID 11222420.
  10. Smeeth L, Cook C, Fombonne E; et al. (2004). "Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001". BMC Med. 2: 39. doi:10.1186/1741-7015-2-39. PMID 15535890.

Template:WH Template:WS